Argentarii’s AbbVie ABBV Stock Holding History

Argentarii’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$916K	Buy	4,212 +27	+0.6%	+$5.99K	0.32%	74
2025 Q4	$956K	Buy	4,185 +802	+24%	+$183K	0.31%	70
2025 Q3	$783K	Sell	3,383 -91	-3%	-$18.5K	0.31%	68
2025 Q2	$645K	Sell	3,474 -509	-13%	-$94.6K	0.3%	79
2025 Q1	$835K	Sell	3,983 -128	-3%	-$24.9K	0.41%	63
2024 Q4	$731K	Buy	+4,111	New	+$756K	0.37%	64

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Argentarii's ABBV Position: Q1 2026 in Review

Argentarii increased its AbbVie (ABBV) stake by 0.65% in Q1 2026, buying an estimated $5.99K and bringing the position to 4,212 shares worth $916K. The position accounts for 0.32% of the portfolio, ranked #74.

Argentarii first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $956K in Q4 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Argentarii held 4,212 shares of AbbVie worth $916K as of Q1 2026.
Argentarii bought 27 AbbVie shares in Q1 2026, an estimated $5.99K.
AbbVie made up 0.32% of Argentarii's portfolio in Q1 2026, its #74 holding.
Argentarii first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
Argentarii's AbbVie position peaked at $956K in Q4 2025.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Argentarii's 13F filing for Q1 2026, filed 12 May 2026.